Navalign LLC’s Aurora Cannabis ACB Stock Holding History

Navalign LLC’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26	Closed	-$110	–	130
2025 Q4	$110	Buy	+26	New	+$127	﹤0.01%	488

Other funds holding ACB

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Navalign LLC's ACB Position: Q1 2026 in Review

Navalign LLC sold out of Aurora Cannabis (ACB) in Q1 2026, closing a stake of 26 shares — an estimated $110 sold.

Navalign LLC first reported a position in ACB in Q4 2025 and held it in 1 quarter. The position peaked at $110 in Q4 2025. 155 funds tracked by Wall St. Rank hold ACB as of Q1 2026.

Navalign LLC reported no remaining Aurora Cannabis position as of Q1 2026 after selling out during the quarter.
Navalign LLC sold 26 Aurora Cannabis shares in Q1 2026, an estimated $110.
Navalign LLC first reported a position in Aurora Cannabis in Q4 2025 and held it in 1 quarter.
Navalign LLC's Aurora Cannabis position peaked at $110 in Q4 2025.
155 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.